TITLE

INCIDENCE OF CARBAPENEM-RESISTANT PSEUDOMONAS AERUGINOSA IN DIABETES AND CANCER PATIENTS

PUB. DATE
July 2008
SOURCE
Indian Journal of Medical Microbiology;Jul2008, Vol. 26 Issue 3, p238
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
33381167

 

Related Articles

  • Incidence of metallo beta lactamase producing Pseudomonas aeruginosa in ICU patients. Varaiya, Ami; Kulkarni, Nikhil; Kulkarni, Manasi; Bhalekar, Pallavi; Dogra, Jyotsana // Indian Journal of Medical Research;Apr2008, Vol. 127 Issue 4, p398 

    Background & objectives: Metallo beta lactamase (MBL) producing Pseudomonas aeruginosa have been reported to be important cause of nosocomial infections. The appearance of MBL genes and their spread among bacterial pathogens is a matter of concern with regard to the future of antimicrobial...

  • Breathe Easy. Karl, E. // Diabetes Health;Aug2005, Vol. 14 Issue 8, p57 

    Focuses on the risk of lung cancer for diabetics. Calculation of lung cancer incidence among diabetic patients in Great Britain; Proneness of diabetics to lung cancer.

  • An Overview on the Role of Microbial Agents in Psoriasis. Sarvtin, Mehdi Taheri; Hedayati, Mohammad Taghi; Ayatollahi Mosavi, Seyed Amin; Afsarian, Mohammad Hosein // Journal of Mazandaran University of Medical Sciences (JMUMS);Mar2013, Vol. 23 Issue 98, p363 

    Background and purpose: Psoriasis is a chronic inflammatory skin disease characterized by lesions covered with silvery-white scabs of dead skin. This autoimmune disease occurs when the immune system sends out faulty signals that speed up the growth cycle of skin cells. Prevalence of psoriasis in...

  • Diabetes increased risk for breast, colorectal cancers. Todak, Alexandra // Hem/Onc Today;11/25/2013, Vol. 14 Issue 22, p18 

    The author comments on a study which found that diabetic patients were at increased risk for breast and colorectal cancer incidence and mortality.

  • Metformin and the Incidence of Cancer in Patients With Diabetes: A Nested Case-Control Study. SHU-YI WANG; CHIEH-SEN CHUANG; CHIH-HSIN MUO; SHIH-TE TU; MING-CHIA LIN; FUNG-CHANG SUNG; CHIA-HUNG KAO // Diabetes Care;Sep2013, Vol. 36 Issue 9, pe155 

    A letter to the editor is presented discussing a study on the association between metformin and the incidence of cancer in diabetic patients.

  • COMMENTS AND RESPONSES. SHIH-WEI LAI; KUAN-FU LIAO; SUISSA, SAMY; AZOULAY, LAURENT // Diabetes Care;Mar2013, Vol. 36 Issue 3, pe40 

    A letter to the editor is presented in response to the article "The Use of Metformin and the Incidence of Lung Cancer in Patients with Type 2 Diabetes," published in an previous issue of "Diabetes Care."

  • insulin use doubles risk of colorectal tumours. Kelly, Brian // Pulse;10/25/2004, Vol. 64 Issue 42, p15 

    Reports on a study of the risk of colorectal cancer among patients with type 2 diabetes on insulin in Great Britain. Incidence of colorectal cancer in type 2 diabetes; Threshold needed for referring insulin users for colorectal screening.

  • Population-Based Study of the Epidemiology and the Risk Factors for Pseudomonas aeruginosa Bloodstream Infection. Parkins, M. D.; Gregson, D. B.; Pitout, J. D. D.; Ross, T.; Laupland, K. B. // Infection;Feb2010, Vol. 38 Issue 1, p25 

    Detailed population-based data on the epidemiologyof Pseudomonas aeruginosa bloodstream infectionsare sparse. We sought to describe the incidence rate, riskfactors, and outcomes associated with P. aeruginosa bacteremiain a large Canadian health region. A retrospective...

  • Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment. Ranc, Kristina; Jørgensen, Marit; Friis, Søren; Carstensen, Bendix // Diabetologia;May2014, Vol. 57 Issue 5, p927 

    Aims/hypothesis: The prognostic role of different diabetes treatment types has not been studied in detail. We compared mortality rates among cancer patients with and without diabetes, accounting for diabetes treatment and diabetes duration. Methods: This register-based study included all cancer...

  • Mysterious Metformin. CHONG, CURTIS R.; CHABNER, BRUCE A. // Oncologist;Dec2009, Vol. 14 Issue 12, p1178 

    In this article, the authors discuss the role of metformin for the treatment of cancer. According to the authors, metformin lowers the risk for several types of cancer in type 2 diabetics. The authors say that patients with diabetes are at a higher risk for cancer; and in patients with type 2...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics